Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Renzhi Han

Showing results (1-10 of 77) with videos related to

Pageof 8
Sort By:
Skeletal Muscle|July 30, 2011
Muscle membrane repair and inflammatory attack in dysferlinopathyRenzhi Han
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 5, 2024
Hit-and-run epigenome editing durably lowers cholesterol in miceRenzhi Han
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 17, 2023
First in vivo base-editing trial shows promiseRenzhi Han
Molecular Therapy. Nucleic Acids|January 26, 2026
Dystrophin rescue in the brain for DMDMengzhen Li, Renzhi Han
Molecular Therapy. Nucleic Acids|July 10, 2024
Targeting miR-25 to alleviate DMD-related muscle dysfunctionShuang Li, Renzhi Han
Toxicology and Applied Pharmacology|September 10, 2005
The effect of the PKC inhibitor calphostin C and the PKC agonist phorbol 12-myristate 13-acetate on regulation of cytosolic Ca(2+) in mammalian skeletal muscle cellsRenzhi Han, Anthony J Bakker
Current Opinion in Cell Biology|July 31, 2007
Dysferlin and muscle membrane repairRenzhi Han, Kevin P Campbell
British Journal of Pharmacology|February 6, 2003
The effect of chelerythrine on depolarization-induced force responses in skinned fast skeletal muscle fibres of the ratRenzhi Han, Anthony J Bakker
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 20, 2024
Rapidly evolving genome and epigenome editing technologiesNgoc Tung Tran, Renzhi Han
Molecular Therapy. Nucleic Acids|April 10, 2025
An oversized AAV8 vector to deliver CPS1Shuang Li, Chen Zhang, Renzhi Han
Pageof 8

Showing results (1-10 of 77) with videos related to

Sort By:
Pageof 8
Skeletal Muscle|July 30, 2011
Muscle membrane repair and inflammatory attack in dysferlinopathyRenzhi Han
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 5, 2024
Hit-and-run epigenome editing durably lowers cholesterol in miceRenzhi Han
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 17, 2023
First in vivo base-editing trial shows promiseRenzhi Han
Molecular Therapy. Nucleic Acids|January 26, 2026
Dystrophin rescue in the brain for DMDMengzhen Li, Renzhi Han
Molecular Therapy. Nucleic Acids|July 10, 2024
Targeting miR-25 to alleviate DMD-related muscle dysfunctionShuang Li, Renzhi Han
Toxicology and Applied Pharmacology|September 10, 2005
The effect of the PKC inhibitor calphostin C and the PKC agonist phorbol 12-myristate 13-acetate on regulation of cytosolic Ca(2+) in mammalian skeletal muscle cellsRenzhi Han, Anthony J Bakker
Current Opinion in Cell Biology|July 31, 2007
Dysferlin and muscle membrane repairRenzhi Han, Kevin P Campbell
British Journal of Pharmacology|February 6, 2003
The effect of chelerythrine on depolarization-induced force responses in skinned fast skeletal muscle fibres of the ratRenzhi Han, Anthony J Bakker
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 20, 2024
Rapidly evolving genome and epigenome editing technologiesNgoc Tung Tran, Renzhi Han
Molecular Therapy. Nucleic Acids|April 10, 2025
An oversized AAV8 vector to deliver CPS1Shuang Li, Chen Zhang, Renzhi Han
Pageof 8